Peptide Concentration Guide: 10mg, 20mg, 30mg & 50mg Vials, mg/mL and mcg Explained
Share
Research peptide vials are commonly labelled by total mass — for example 10mg, 20mg, 30mg or 50mg. That number is important, but it does not by itself tell you the concentration of a prepared laboratory solution, how many micrograms are present in a measured volume, or what solvent volume a validated laboratory method should use.
This guide explains the maths behind mg, mL, mg/mL and mcg, provides worked concentration examples for 10mg, 20mg, 30mg and 50mg vial strengths, and explains how a U-100 syringe scale relates to volume. It also uses commonly encountered research peptides such as Retatrutide, BPC-157, TB-500, GHK-Cu, CJC-1295, Ipamorelin, Tesamorelin and MOTS-c as reference examples for why peptide identity and chemistry matter.
Research-use scope: The calculations below are laboratory concentration examples only. They are not instructions for human administration, dosing or a recommendation to use any particular diluent volume. A laboratory method should be based on the material's identity, validated SOP, solvent compatibility, analytical objective and supporting documentation.
What does 10mg, 20mg, 30mg or 50mg on a peptide vial mean?
The mg value is a mass. A vial labelled 10mg is describing 10 milligrams of stated material; 20mg describes 20 milligrams; 30mg describes 30 milligrams; and 50mg describes 50 milligrams. The label does not, by itself, define a concentration because concentration requires both a mass and a volume.
This distinction is one of the most important concepts in laboratory peptide calculations:
- mg = milligrams, a unit of mass.
- mcg = micrograms, a smaller unit of mass. 1mg = 1,000mcg.
- mL = millilitres, a unit of liquid volume.
- mg/mL = milligrams per millilitre, a concentration.
Two samples can contain the same total mass but have very different concentrations if their final solution volumes are different.
The core concentration formula
The fundamental calculation is:
Concentration (mg/mL) = mass (mg) ÷ final volume (mL)
The formula can also be rearranged:
Mass (mg) = concentration (mg/mL) × volume (mL)
Volume (mL) = mass (mg) ÷ concentration (mg/mL)
For micrograms:
1mg = 1,000mcg
Therefore, a concentration of 5mg/mL is mathematically the same as 5,000mcg/mL.
10mg, 20mg, 30mg and 50mg: concentration examples
The following matrix is deliberately presented as mathematical final-volume examples, not as a reconstitution protocol. It shows what the concentration would be if a laboratory method had already established a particular final solution volume.
| Labelled mass | 1mL final volume | 2mL final volume | 3mL final volume | 5mL final volume |
|---|---|---|---|---|
| 10mg | 10mg/mL | 5mg/mL | 3.33mg/mL | 2mg/mL |
| 20mg | 20mg/mL | 10mg/mL | 6.67mg/mL | 4mg/mL |
| 30mg | 30mg/mL | 15mg/mL | 10mg/mL | 6mg/mL |
| 50mg | 50mg/mL | 25mg/mL | 16.67mg/mL | 10mg/mL |
For example, the maths behind the 10mg row is simple: 10mg ÷ 2mL = 5mg/mL. That same 5mg/mL concentration can also be expressed as 5,000mcg/mL.
Important: the table does not tell a researcher which volume should be used. It only shows the resulting concentration after a final volume has been defined by an appropriate method.
Understanding a U-100 syringe scale as a volume scale
A U-100 insulin syringe is calibrated so that the 100-unit mark corresponds to 1.00mL for U-100 insulin. When the barrel is being discussed purely as a volume-measuring scale, the 10-unit mark corresponds to 0.10mL, the 20-unit mark to 0.20mL and so on.
The word units on this syringe should not be confused with milligrams or micrograms of a peptide. A syringe marking tells you a volume. To calculate the mass contained within that volume, you must already know the solution concentration.
Worked mathematical example
Suppose a laboratory solution has a known concentration of 5mg/mL. A measured volume of 0.10mL contains:
5mg/mL × 0.10mL = 0.5mg
Converting milligrams to micrograms:
0.5mg × 1,000 = 500mcg
This example demonstrates the relationship between concentration, volume and mass. It is not a dosing recommendation.
Why there is no universal “BAC water per mg” rule
It is tempting to assume that every 10mg vial should receive the same liquid volume, every 20mg vial another fixed volume, and so on. Scientifically, that is not a reliable rule.
Peptides differ in sequence, molecular structure, charge, hydrophobicity, formulation, counter-ion, excipients and solubility behaviour. Laboratory suppliers such as MilliporeSigma and GenScript publish peptide handling and solubility guidance precisely because solvent choice and achievable concentration can vary between peptide materials and experimental requirements.
For that reason, a vial's mass label answers the question “how much stated material is present?” It does not automatically answer “what final volume should this laboratory method use?”
Before preparing a solution for legitimate laboratory work, researchers should identify the compound, review its product documentation and COA, confirm solvent compatibility, define the concentration required by the assay, and follow the relevant validated SOP or method.
What is bacteriostatic water?
Bacteriostatic Water for Injection, USP is described in the US DailyMed label as sterile water containing 0.9% benzyl alcohol as a bacteriostatic preservative in a multiple-dose container. That definition explains what bacteriostatic water is; it does not mean it is automatically the correct solvent for every research peptide or every laboratory procedure.
Solvent compatibility should be established for the specific material and analytical method. For a broader explanation, see our laboratory guide to bacteriostatic water.
Common peptide references: why identity matters more than vial strength
Australian research catalogues and official peptide education materials repeatedly reference compounds such as Retatrutide, BPC-157, TB-500, GHK-Cu, CJC-1295, Ipamorelin, Tesamorelin and MOTS-c. These names cover chemically and biologically different molecules; the fact that two products may both be labelled 10mg does not make them interchangeable from a solubility or laboratory-method perspective.
Retatrutide
Retatrutide is an investigational peptide being studied in clinical development, including the Phase 3 TRIUMPH programme. A Retatrutide vial strength is a mass statement; it should not be treated as a universal concentration or preparation instruction. Read our What Is Retatrutide? guide for background on the compound.
BPC-157 and TB-500
BPC-157 and TB-500 are frequently encountered in online research-peptide discussions and are also specifically identified in Australian regulatory and sport-integrity material concerning unapproved peptides. Their names, sequences and material properties differ, so a concentration calculation should never be substituted for compound-specific handling information. See our BPC-157 research guide and TB-500 research guide.
GHK-Cu
GHK-Cu is a copper complex of the tripeptide glycyl-L-histidyl-L-lysine. Its chemistry illustrates why a mass label alone cannot define a universal solvent method. Read more in What Is GHK-Cu?.
CJC-1295, Ipamorelin and Tesamorelin
CJC-1295, Ipamorelin and Tesamorelin are often grouped together conversationally because of their research context around growth-hormone signalling, but they are distinct molecules. Ipamorelin is a small peptide secretagogue, while CJC-1295 and Tesamorelin are structurally different GHRH-related research compounds. The same mg number on different vials therefore does not imply the same physicochemical handling.
MOTS-c
MOTS-c is a mitochondria-derived peptide studied in metabolic research. Again, vial mass and solution concentration are separate variables. See What Is MOTS-c?.
COA purity is not the same thing as vial concentration
Another common calculation error is to treat an HPLC purity percentage as though it directly defines the milligrams in a vial. Those are separate analytical questions.
HPLC purity generally describes the relative chromatographic purity of the detected material under the stated method. Content or quantity addresses how much target material is actually present. A COA may report one or both, depending on the analytical method used.
For that reason, it is not automatically valid to take a vial label, multiply it by an HPLC purity percentage and assume the result is the exact peptide mass. Read Understanding HPLC Purity, Certificate of Analysis Explained, and How to Verify a Peptide COA and Batch Number for more detail.
Common concentration calculation mistakes
- Confusing mass with concentration: 10mg is not the same as 10mg/mL.
- Assuming one liquid volume fits every peptide: compound identity and method requirements matter.
- Confusing U-100 syringe markings with peptide mass: the barrel scale represents a volume calibration, not milligrams or micrograms of an unknown solution.
- Forgetting the mg-to-mcg conversion: 1mg = 1,000mcg.
- Ignoring final volume: concentration calculations use the total final solution volume.
- Treating purity percentage as quantity: HPLC purity and assayed content are not automatically interchangeable.
- Skipping documentation: batch number, COA, storage conditions and the laboratory SOP should all be recorded.
Frequently asked questions
How much bacteriostatic water goes with a 10mg peptide vial?
A 10mg label alone is not enough information to select a scientifically appropriate solvent volume. The correct laboratory method depends on the specific peptide, solvent compatibility, required assay concentration and validated protocol. Once a final volume has been defined, concentration is calculated as 10mg divided by that final volume.
What about a 20mg, 30mg or 50mg vial?
The same principle applies. A larger mg number changes the total labelled mass, not the scientific requirement to define an appropriate method. Use mass ÷ final volume = concentration after the method has established the final volume.
Does 10 units on a U-100 syringe equal 0.10mL?
On a genuine U-100 insulin syringe scale, the 100-unit mark corresponds to 1.00mL, so the 10-unit mark corresponds to 0.10mL as a volume reading. This does not tell you how many mg or mcg are present unless the solution concentration is already known.
How do I convert mg/mL to mcg/mL?
Multiply the mg/mL value by 1,000. For example, 5mg/mL = 5,000mcg/mL.
If a solution is 5mg/mL, how many micrograms are in 0.10mL?
5mg/mL × 0.10mL = 0.5mg. Since 1mg = 1,000mcg, 0.5mg = 500mcg. This is a generic concentration calculation only.
Does a 50mg vial always need more solvent than a 10mg vial?
Not necessarily. The required final concentration and the compound's validated laboratory handling method determine the relevant volume. Vial mass alone cannot answer that question.
Australian regulatory context
In a joint statement published on 19 June 2026, Australia's Therapeutic Goods Administration and Chief Medical Officer warned about public-health risks associated with unapproved peptide products. The TGA specifically named BPC-157, GHK-Cu, TB-500, Retatrutide and CJC-1295 among examples of unapproved peptide products that may not have been evaluated by the TGA for safety, quality or effectiveness. Sport Integrity Australia also lists several peptides, including BPC-157, CJC-1295, Ipamorelin, MOTS-C and TB-500, in its education material on unapproved peptides and anti-doping.
Australian Peptide supplies materials for laboratory research purposes only. This article is educational content about laboratory measurement and concentration calculations and does not provide medical or self-administration advice.
Further reading
- What Are Research Peptides?
- Laboratory Storage of Research Peptides
- Research Peptide Quality Standards
- Understanding HPLC Purity
- Certificate of Analysis Explained
- How to Verify a Peptide COA and Batch Number in Australia
Research sources
- MilliporeSigma — Handling and Storage Guidelines for Peptides and Proteins
- GenScript — Peptide Solubility Testing
- DailyMed — Bacteriostatic Water for Injection, USP
- ClinicalTrials.gov — Retatrutide TRIUMPH-1 (NCT05929066)
- Therapeutic Goods Administration — Concerns regarding unapproved peptide products, 19 June 2026
- Sport Integrity Australia — Peptides Explained
Last reviewed: September 2026. Information is provided for laboratory research education only.